Related Experiment Video
Updated: Jan 4, 2026

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
Protease-Activated Receptors in the Intestine: Focus on Inflammation and Cancer
Morgane Sébert1, Nuria Sola-Tapias1, Emmanuel Mas1
1IRSD, INSERM (U1220), INRA, ENVT, UPS, Université de Toulouse, Toulouse, France.
Abstract:
Protease-activated receptors (PARs) belong to the G protein-coupled receptor (GPCR) family. Compared to other GPCRs, the specificity of the four PARs is the lack of physiologically soluble ligands able to induce their activation. Indeed, PARs are physiologically activated after proteolytic cleavage of their N-terminal domain by proteases. The resulting N-terminal end becomes a tethered activation ligand that interact with the extracellular loop 2 domain and thus induce PAR signal. PARs expression is ubiquitous and these receptors have been largely described in chronic inflammatory diseases and cancer. In this review, after describing their discovery, structure, mechanisms of activation, we then focus on the roles of PARs in the intestine and the two main diseases affecting the organ, namely inflammatory bowel diseases and cancer.
Insights
Protease-activated receptors (PARs) are unique G protein-coupled receptors activated by proteases, not soluble ligands. This review explores PARs roles in the intestine, focusing on inflammatory bowel diseases and cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Biology
Background:
- Protease-activated receptors (PARs) are a distinct subclass of G protein-coupled receptors (GPCRs).
- Unlike other GPCRs, PARs lack soluble ligands and are activated through proteolytic cleavage of their extracellular N-terminal domain.
- The cleaved N-terminus acts as a tethered ligand, initiating intracellular signaling cascades.
Purpose of the Study:
- To review the discovery, structure, and activation mechanisms of PARs.
- To elucidate the specific roles of PARs in intestinal physiology.
- To examine the involvement of PARs in inflammatory bowel diseases (IBD) and colorectal cancer.
Main Methods:
- Literature review of existing research on PARs.
- Analysis of PARs expression patterns in intestinal tissues.
- Synthesis of data on PARs signaling pathways in disease contexts.
Main Results:
- PARs are ubiquitously expressed and play critical roles in various physiological processes.
- Dysregulation of PARs signaling is implicated in the pathogenesis of IBD and cancer.
- Specific PAR subtypes demonstrate distinct functions in intestinal inflammation and tumorigenesis.
Conclusions:
- PARs represent crucial targets for therapeutic interventions in intestinal diseases.
- Further research into PARs biology is warranted to develop novel treatment strategies for IBD and cancer.
- Understanding PARs activation and signaling is key to addressing gastrointestinal pathologies.
More Related Videos
07:32An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
Published on: December 3, 2020
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Renewal of Intestinal Stem Cells
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...